BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28928419)

  • 1. The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.
    Samant SA; Kanwal A; Pillai VB; Bao R; Gupta MP
    Sci Rep; 2017 Sep; 7(1):11877. PubMed ID: 28928419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of activins promotes muscle wasting and cachexia.
    Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
    FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.
    Lee SJ; Lehar A; Meir JU; Koch C; Morgan A; Warren LE; Rydzik R; Youngstrom DW; Chandok H; George J; Gogain J; Michaud M; Stoklasek TA; Liu Y; Germain-Lee EL
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23942-23951. PubMed ID: 32900939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.
    Castillero E; Akashi H; Wang C; Najjar M; Ji R; Kennel PJ; Sweeney HL; Schulze PC; George I
    Biochem Biophys Res Commun; 2015 Jan; 457(1):106-11. PubMed ID: 25528587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.
    Gilson H; Schakman O; Kalista S; Lause P; Tsuchida K; Thissen JP
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E157-64. PubMed ID: 19435857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency of myostatin protects against aging-related declines in muscle function and enhances the longevity of mice.
    Mendias CL; Bakhurin KI; Gumucio JP; Shallal-Ayzin MV; Davis CS; Faulkner JA
    Aging Cell; 2015 Aug; 14(4):704-6. PubMed ID: 25808276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
    Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
    Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.
    Heineke J; Auger-Messier M; Xu J; Sargent M; York A; Welle S; Molkentin JD
    Circulation; 2010 Jan; 121(3):419-25. PubMed ID: 20065166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice.
    Allen DL; Cleary AS; Lindsay SF; Loh AS; Reed JM
    J Appl Physiol (1985); 2010 Sep; 109(3):692-701. PubMed ID: 20595541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy.
    Wójcik S; Nogalska A; Engel WK; Askanas V
    Folia Morphol (Warsz); 2008 Feb; 67(1):6-12. PubMed ID: 18335407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling.
    Tian K; Liu Z; Wang J; Xu S; You T; Liu P
    Transl Res; 2015 Mar; 165(3):374-86. PubMed ID: 25475987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
    Lee SJ; Lehar A; Liu Y; Ly CH; Pham QM; Michaud M; Rydzik R; Youngstrom DW; Shen MM; Kaartinen V; Germain-Lee EL; Rando TA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30907-30917. PubMed ID: 33219121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
    Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Activin A and Myostatin in cancer cachexia].
    Thissen JP; Loumaye A
    Ann Endocrinol (Paris); 2013 May; 74(2):79-81. PubMed ID: 23566617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
    Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
    Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
    Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB.
    Sriram S; Subramanian S; Sathiakumar D; Venkatesh R; Salerno MS; McFarlane CD; Kambadur R; Sharma M
    Aging Cell; 2011 Dec; 10(6):931-48. PubMed ID: 21771249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.